SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer

NCT07297030 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

RADIATION: SIB-SCRT
DRUG: CAPOX
DRUG: Immunotherapy

Sponsor

Sun Yat-sen University